Category: Pharmaceuticals
Pharmaceuticals market research reports by Plunkett Research, Ltd.
-
Financial Analysis and Multi-Year Benchmarking: Curis Inc (CRIS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Curis Inc (CRIS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Curis Inc (CRIS:NAS). Includes Industry Averages & Top Competitors, KPIs ... Read More
-
Financial Analysis and Multi-Year Benchmarking: BioMarin Pharmaceutical Inc (BMRN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: BioMarin Pharmaceutical Inc (BMRN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: BioMarin Pharmaceutical Inc (BMRN:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Bio-Rad Laboratories Inc (BIO:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Bio-Rad Laboratories Inc (BIO:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Bio-Rad Laboratories Inc (BIO:NYS). Includes Industry Aver ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Exelixis Inc (EXEL:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Exelixis Inc (EXEL:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Exelixis Inc (EXEL:NAS). Includes Industry Averages & Top Competitors ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Abbott Laboratories (ABT:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Abbott Laboratories (ABT:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Abbott Laboratories (ABT:NYS). Includes Industry Averages & Top ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Waverley Pharma Inc (WAVE:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Waverley Pharma Inc (WAVE:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Waverley Pharma Inc (WAVE:TSX). Includes Industry Averages & T ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Aurinia Pharmaceuticals Inc (AUPH:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Aurinia Pharmaceuticals Inc (AUPH:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Aurinia Pharmaceuticals Inc (AUPH:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Knight Therapeutics Inc (GUD:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Knight Therapeutics Inc (GUD:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Knight Therapeutics Inc (GUD:TSE). Includes Industry Averag ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Arbutus Biopharma Corp (ABUS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Arbutus Biopharma Corp (ABUS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Arbutus Biopharma Corp (ABUS:NAS). Includes Industry Averag ... Read More
-
Financial Analysis and Multi-Year Benchmarking: HLS Therapeutics Inc (HLS:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: HLS Therapeutics Inc (HLS:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: HLS Therapeutics Inc (HLS:TSE). Includes Industry Averages & T ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Eupraxia Pharmaceuticals Inc (EPRX:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Eupraxia Pharmaceuticals Inc (EPRX:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Eupraxia Pharmaceuticals Inc (EPRX:TSE). Includes Ind ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Medexus Pharmaceuticals Inc (MDP:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Medexus Pharmaceuticals Inc (MDP:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Medexus Pharmaceuticals Inc (MDP:TSE). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Aequus Pharmaceuticals Inc (AQS:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Aequus Pharmaceuticals Inc (AQS:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Aequus Pharmaceuticals Inc (AQS:TSX). Includes Industry ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Valeo Pharma Inc (VPH:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Valeo Pharma Inc (VPH:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Valeo Pharma Inc (VPH:TSE). Includes Industry Averages & Top Compe ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Avant Brands Inc (AVNT:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Avant Brands Inc (AVNT:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Avant Brands Inc (AVNT:TSE). Includes Industry Averages & Top Com ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Theralase Technologies Inc (TLT:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Theralase Technologies Inc (TLT:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Theralase Technologies Inc (TLT:TSX). Includes Industry ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Nymox Pharmaceutical Corporation (NYMXF:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Nymox Pharmaceutical Corporation (NYMXF:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Nymox Pharmaceutical Corporation (NYMXF:PINX). ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Milestone Pharmaceuticals Inc (MIST:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Milestone Pharmaceuticals Inc (MIST:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Milestone Pharmaceuticals Inc (MIST:NAS). Includes I ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Cipher Pharmaceuticals Inc (CPH:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Cipher Pharmaceuticals Inc (CPH:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Cipher Pharmaceuticals Inc (CPH:TSE). Includes Industry ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325411
Revenue Forecasts to (2031) and Analytics for the Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325411 Revenue Forecasts to (2031) and Analytics for the Vitamins, Botanicals, Nutritional Supplements and Medi ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325400
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325400 Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.): Fina ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000
Revenue Forecasts to (2031) and Analytics for the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000 Revenue Forecasts to (2031) and Analytics for the Drug Stores and Pharmacies (Pharmacy), plus Nutri ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424210
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424210 Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Financial Benchmar ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424200
Revenue Forecasts to (2031) and Analytics for the Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424200 Revenue Forecasts to (2031) and Analytics for the Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors (U.S.): Fi ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414 Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.) ... Read More
Research Assistance
